Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Raloxifene in Recurrent Endometrial Cancer

NCT00004915 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00004915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Raloxifene in Recurrent Endometrial Cancer
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
November 30, 1998
Completion date
February 29, 2000
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer